Table 2.
Items | Treatment | ||
---|---|---|---|
CON | ZnO | C_ZnO | |
Growth performance | |||
IBW, kg | 7.0 ± 0.50 | 7.0 ± 0.50 | 7.0 ± 0.50 |
EBW, kg | 24.30 ± 0.51c | 25.67 ± 0.54b | 26.8 ± 0.55a |
ADG, g | 412.10 ± 35.23c | 444.50 ± 33.76b | 471.50 ± 29.32a |
ADFI, g | 704.69 ± 54.02 | 733.43 ± 46.19 | 749.69 ± 34.46 |
F/G | 1.71 ± 0.25a | 1.65 ± 0.24b | 1.59 ± 0.22c |
Diarrhea incidence, % | |||
1–3 week | 31.90 ± 0.15a | 23.10 ± 0.10b | 22.10 ± 0.11b |
3–6 week | 25.10 ± 0.09a | 17.30 ± 0.11b | 15.50 ± 0.10b |
L/M | 0.599 ± 0.02a | 0.249 ± 0.07b | 0.234 ± 0.01b |
Data of growth performance and diarrhea incidence were shown as mean ± SEM (n = 42). Data of L/M were shown as mean ± SEM (n = 6). Different superscript within a row means significantly different (P <0.05).
IBW, initial body weight; EBW, end bodyweight; ADG, average daily gain; ADFI, average daily feed intake; F/G, feed to gain ratio; L/M, lactulose/mannitol; CON, basal diet; ZnO, basal diet supplemented with ZnO (2,000 mg Zn/kg); C_ZnO, basal diet supplemented with C_ZnO (500 mg Zn/kg).